Update on the Office of Drug Safety at the US FDA

The Drug Information Association Annual Meeting [Washington, DC, USA, Jun 13-17, 2004] hosted an interactive panel discussion on the structure and function of the new Office of Drug Safety (ODS) and some of the activities in which this office has recently been engaged in. Delegates heard about safety signal detection/data-mining initiatives, drug-induced liver-injury, developments in assessing risk management plans and medication-error issues.